Wearable Technology to Reduce Sedentary Behavior and CVD Risk in Older Adults

Exclusion Criteria

• •Failure to provide informed consent;
• •Regular participation in an exercise training program within the last 3 months
• •Absolute contraindication(s) to exercise training (American College of Sports Medicine guidelines)
• •Office SBP \> 180 mm Hg or DBP \> 110 mm Hg
• •Severe cardiac disease, i.e. NYHA Class III or IV congestive heart failure, clinically significant aortic stenosis, history of cardiac arrest, use of a cardiac defibrillator, or uncontrolled angina;
• •Myocardial infarction or stroke within past year
• •Significant cognitive impairment, i.e. known dementia or a Mini-Mental State Examination score \< 24
• •Progressive, degenerative neurologic disease, e.g., Parkinson's Disease, multiple sclerosis, ALS;
• •Severe rheumatologic/orthopedic disease, e.g., awaiting joint replacement, active inflammatory disease
• •Severe pulmonary disease, requiring either steroid pills or injections or the use of supplemental oxygen;
• •Hip fracture, hip or knee replacement, or spinal surgery within past 4 months;
• •Other significant co-morbid conditions that would impair ability to participate in the intervention
• •Simultaneous participation in another intervention trial